The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen a...
Saved in:
Published in | Frontiers in aging neuroscience Vol. 16; p. 1347987 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Research Foundation
12.04.2024
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson’s disease, Alzheimer’s, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders. |
---|---|
AbstractList | Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson’s disease, Alzheimer’s, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders. Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson's disease, Alzheimer's, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders.Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and neurodegenerative diseases. This is a cellular immune response whereby glial cells are activated, inflammatory mediators are liberated and reactive oxygen and nitrogen species are synthesized. Neuroinflammation is a key process that helps protect the brain from pathogens, but inappropriate, or protracted inflammation yields pathological states such as Parkinson's disease, Alzheimer's, Multiple Sclerosis, and other neurodegenerative disorders that showcase various pathways of neurodegeneration distributed in various parts of the CNS. This review reveals the major neuroinflammatory signaling pathways associated with neurodegeneration. Additionally, it explores promising therapeutic avenues, such as stem cell therapy, genetic intervention, and nanoparticles, aiming to regulate neuroinflammation and potentially impede or decelerate the advancement of these conditions. A comprehensive understanding of the intricate connection between neuroinflammation and these diseases is pivotal for the development of future treatment strategies that can alleviate the burden imposed by these devastating disorders. |
Author | Li, Shuo Adamu, Alhamdu Gao, Fankai Xue, Guofang |
Author_xml | – sequence: 1 givenname: Alhamdu surname: Adamu fullname: Adamu, Alhamdu – sequence: 2 givenname: Shuo surname: Li fullname: Li, Shuo – sequence: 3 givenname: Fankai surname: Gao fullname: Gao, Fankai – sequence: 4 givenname: Guofang surname: Xue fullname: Xue, Guofang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38681666$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1vEzEQhi1URNvQP8ABWeLCJcFfa3u5oQpKpUpcytnyesdbRxs7tb1I_HvcJFSoB3wZa_y8M2PNe4nOYoqA0DtKNpzr_pOPdgobRpjYUC5Ur9UrdEGl5GvBZXf2z_0cXZWyJe1wTkin36BzrqVu7_ICPd4_AM5pBpw8jrDkFKKf7W5na0gRh3hMjjBBhNySvwCPoYAtUD5jt-QMseIljpBLtXEMccItYL_UJQOuD020h6UGh6vNE9TyFr32di5wdYor9PPb1_vr7-u7Hze311_u1k4IWteKetYzqYDrEUaqiRODtZ10VFHREeHUyITmuvNUc9UTaakWAgZmNYDSwFfo9lh3THZr9jnsbP5tkg3mkEh5Mja3uWYwzHHBQXrCeOsyyMF6r3vnJHXSSu1arY_HWvucHhco1exCcTDPNkJaiuFEaNGLjrGGfniBbtOSY_tpo7iifa_aHlbo_Ylahh2Mz-P9XUwD2BFwOZWSwT8jlJgnA5iDAcyTAczJAE2kX4hcqIdF1mzD_D_pHwRdt1c |
CitedBy_id | crossref_primary_10_1016_j_fbio_2024_105799 crossref_primary_10_1016_j_fitote_2024_106173 crossref_primary_10_3390_biomedicines12122670 crossref_primary_10_1186_s40035_024_00435_8 crossref_primary_10_1155_2024_9965893 crossref_primary_10_3390_ijms25189859 crossref_primary_10_3390_ph17101391 crossref_primary_10_3390_ijms25126488 crossref_primary_10_3724_zdxbyxb_2024_0208 crossref_primary_10_1016_j_molmed_2025_01_009 crossref_primary_10_1016_j_tice_2025_102725 crossref_primary_10_26599_NBE_2024_9290099 crossref_primary_10_1097_WCO_0000000000001352 crossref_primary_10_3389_fphar_2025_1540736 crossref_primary_10_1111_cen3_12830 crossref_primary_10_1007_s00702_025_02902_6 crossref_primary_10_1016_j_arr_2024_102450 crossref_primary_10_1016_j_bbr_2025_115510 crossref_primary_10_1016_j_jddst_2024_106413 crossref_primary_10_3390_ijms252312701 crossref_primary_10_3390_neuroglia5040027 crossref_primary_10_3390_ijms252212164 crossref_primary_10_3390_ijms25179588 crossref_primary_10_1007_s12017_025_08843_3 crossref_primary_10_1007_s00204_024_03903_2 crossref_primary_10_22159_ijap_2025v17i2_53425 crossref_primary_10_3389_fphar_2025_1492517 crossref_primary_10_1007_s00210_024_03515_8 crossref_primary_10_1186_s43066_024_00386_9 crossref_primary_10_3390_ijms252312613 crossref_primary_10_59324_ejeba_2024_1_3__08 crossref_primary_10_1016_j_aehs_2025_02_002 crossref_primary_10_3389_fcimb_2024_1421571 crossref_primary_10_3390_cimb47010008 crossref_primary_10_3390_jpm14111081 crossref_primary_10_4103_ed_ed_16_24 crossref_primary_10_3390_jcm14020386 crossref_primary_10_3390_ijms252413614 crossref_primary_10_3390_antiox13121462 crossref_primary_10_1007_s12035_025_04808_6 crossref_primary_10_1186_s13148_025_01820_4 crossref_primary_10_32604_biocell_2024_058405 crossref_primary_10_3390_microorganisms13010090 crossref_primary_10_3390_ijms25115973 crossref_primary_10_1016_j_biopha_2025_117905 crossref_primary_10_37349_ent_2025_100498 crossref_primary_10_1039_D4RA07798A crossref_primary_10_1111_cns_70053 crossref_primary_10_3390_cimb47020096 crossref_primary_10_3390_ijms25179747 crossref_primary_10_1038_s41538_025_00378_y crossref_primary_10_37349_en_2025_100673 crossref_primary_10_2147_DDDT_S507697 crossref_primary_10_3390_biomedicines12081894 crossref_primary_10_1089_neur_2024_0116 crossref_primary_10_1155_adpp_2869332 crossref_primary_10_1016_j_dscb_2025_100193 crossref_primary_10_1016_j_arr_2024_102544 crossref_primary_10_3390_antiox13111354 crossref_primary_10_3390_nu17030558 crossref_primary_10_3390_biology13121030 crossref_primary_10_1016_j_ejmech_2024_116763 crossref_primary_10_1073_pnas_2410996121 crossref_primary_10_3390_ijms252111638 crossref_primary_10_3390_ijms25137115 crossref_primary_10_3390_biomedicines12112514 |
Cites_doi | 10.3892/ijo.2021.5275 10.1517/17425255.4.10.1265 10.4103/0019-5545.44908 10.3389/fncel.2021.749587 10.1007/s13311-022-01247-2 10.3390/cells12101368 10.3390/sci3010012 10.1186/s40035-020-00221-2 10.1016/j.nbd.2020.104963 10.3389/fnagi.2022.872134 10.3389/fncel.2017.00216 10.1523/JNEUROSCI.23-05-01605.2003 10.1177/1352458520970841 10.3389/fnagi.2021.782082 10.1177/1179573517709278 10.1038/s41392-023-01486-5 10.1101/cshperspect.a009399 10.1016/j.it.2020.07.007 10.1155/2021/8874339 10.2147/IJN.S35333 10.1097/AIA.0b013e318034194e 10.1021/acsomega.3c04862 10.3390/ijms22063027 10.1177/03000605231177191 10.1080/14728222.2018.1486823 10.3389/fphar.2021.643254 10.1016/j.bbamcr.2014.05.014 10.1016/j.tins.2020.10.008 10.1186/s12929-017-0355-7 10.1016/j.biopha.2020.110887 10.3390/cimb45020094 10.1016/j.apsb.2020.01.015 10.3390/cells11071139 10.3390/ijms23052400 10.1038/s41573-020-0082-8 10.3389/fcell.2019.00313 10.1016/j.heliyon.2018.e00508 10.3390/cells9071687 10.1007/s12264-023-01023-y 10.1155/2022/7924199 10.1016/j.ceb.2015.02.004 10.3390/ijms21218060 10.3389/fnins.2019.01310 10.3389/fimmu.2019.02538 10.1097/JCN.0b013e318197a6a5 10.2147/IJN.S347187 10.1146/annurev-immunol-061020-053707 10.1039/d1md00280e 10.1007/s00401-021-02384-2 10.1186/s40035-023-00392-8 10.1155/2021/7834421 10.3389/fnagi.2022.815347 10.3390/biotech11010006 10.1016/j.pharep.2018.11.005 10.7759/cureus.47861 10.3389/fnmol.2020.00148 10.3389/fneur.2021.654739 10.3390/antiox11112287 10.3389/fnins.2017.00680 10.3390/biology12101307 10.5772/67656 10.3233/JAD-215025 10.1038/s41392-023-01452-1 10.3389/fnagi.2021.636545 10.1186/s12974-021-02114-1 10.3390/ijms24129903 10.1155/2021/9931742 10.3389/fnagi.2022.825086 10.1016/j.phrs.2019.104580 10.1186/s12974-020-1731-x 10.2991/efood.k.200203.001 10.1002/wsbm.1583 10.3389/fnins.2020.602508 10.1111/ene.14393 10.3390/polym15071596 10.3390/ph14010029 10.1007/s12035-016-0297-1 10.3748/wjg.v23.i30.5486 10.3390/ma14123332 10.1038/s41392-023-01588-0 10.3390/ijms21228421 10.1038/s41525-021-00243-3 10.3390/ijms23105744 10.3389/fimmu.2022.812774 10.3390/ph15020140 10.1007/978-1-4614-6434-1_174-1 10.3390/biomedicines11061752 10.3390/toxins5020363 10.3389/fnut.2023.1173660 10.3390/cells12151942 10.3389/fncel.2015.00278 10.7150/thno.83066 10.3389/fncel.2018.00329 10.1084/jem.20190945 10.1186/s41232-023-00277-3 10.1016/j.jmb.2019.01.045 10.1177/0271678X20951995 10.1039/D3RA03313A 10.1007/s10753-022-01730-0 10.3389/fncel.2016.00056 10.3390/molecules25204613 10.3390/cells12091231 10.3389/fimmu.2022.1088124 10.3389/fimmu.2019.01265 10.1016/j.nurt.2010.05.014 10.3389/fncel.2021.704884 10.3389/fcell.2021.751079 10.1016/j.neuron.2019.06.010 10.3390/ijms22168363 10.3390/biomedicines6030091 10.4103/1673-5374.306064 10.2147/IJN.S357598 10.3390/ijms23179583 10.18632/oncotarget.23208 10.7150/jca.47022 10.3233/JPD-223278 10.3390/ijms22042153 10.3390/ijms24010604 10.14802/jmd.22141 10.3389/fnmol.2019.00258 10.3389/fphar.2020.00356 10.1111/jnc.13607 10.3390/metabo12111064 10.3389/fnagi.2023.1145241 10.3233/JAD-151013 10.3389/fneur.2023.1103416 10.1186/s12964-017-0177-y 10.5056/jnm18087 10.3389/fimmu.2021.667705 10.3390/biomedicines9050524 10.1186/s40035-021-00271-0 10.1007/s12264-022-00981-z 10.3390/ijms23031851 |
ContentType | Journal Article |
Copyright | Copyright © 2024 Adamu, Li, Gao and Xue. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Copyright © 2024 Adamu, Li, Gao and Xue. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI Q9U 7X8 DOA |
DOI | 10.3389/fnagi.2024.1347987 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1663-4365 |
ExternalDocumentID | oai_doaj_org_article_2c343e6f023c4bb6baff89cc61c6a68c 38681666 10_3389_fnagi_2024_1347987 |
Genre | Journal Article Review |
GroupedDBID | --- 53G 5VS 7X7 88I 8FE 8FH 8FI 8FJ 9T4 AAFWJ AAYXX ABIVO ABUWG ACGFO ACGFS ACXDI ADBBV ADRAZ AEGXH AENEX AFKRA AFPKN AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK DWQXO E3Z EIHBH F5P FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE KQ8 LK8 M2P M48 M7P M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC RNS RPM TR2 UKHRP IAO IEA IHR IHW IPNFZ IPY NPM RIG 3V. 7XB 8FK K9. PKEHL PQEST PQGLB PQUKI Q9U 7X8 PUEGO |
ID | FETCH-LOGICAL-c441t-71f29267e38ded180c4baa56c1714504c7d248385f1837906a1844eb2a8ee78e3 |
IEDL.DBID | M48 |
ISSN | 1663-4365 |
IngestDate | Wed Aug 27 01:31:49 EDT 2025 Fri Jul 11 00:12:26 EDT 2025 Fri Jul 25 11:42:48 EDT 2025 Thu Jan 02 22:39:04 EST 2025 Thu Apr 24 22:56:58 EDT 2025 Tue Jul 01 02:20:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | neurodegenerative disease Alzheimer’s disease neuroinflammation Parkinson’s disease central nervous system |
Language | English |
License | Copyright © 2024 Adamu, Li, Gao and Xue. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c441t-71f29267e38ded180c4baa56c1714504c7d248385f1837906a1844eb2a8ee78e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3037199703?pq-origsite=%requestingapplication% |
PMID | 38681666 |
PQID | 3037199703 |
PQPubID | 4424411 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_2c343e6f023c4bb6baff89cc61c6a68c proquest_miscellaneous_3048494522 proquest_journals_3037199703 pubmed_primary_38681666 crossref_primary_10_3389_fnagi_2024_1347987 crossref_citationtrail_10_3389_fnagi_2024_1347987 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-04-12 |
PublicationDateYYYYMMDD | 2024-04-12 |
PublicationDate_xml | – month: 04 year: 2024 text: 2024-04-12 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Lausanne |
PublicationTitle | Frontiers in aging neuroscience |
PublicationTitleAlternate | Front Aging Neurosci |
PublicationYear | 2024 |
Publisher | Frontiers Research Foundation Frontiers Media S.A |
Publisher_xml | – name: Frontiers Research Foundation – name: Frontiers Media S.A |
References | Griciuc (B39) 2019; 103 Chen (B15) 2021; 9 Khatoon (B60) 2023; 15 Lotfi (B70) 2019; 10 Ben Haim (B5) 2015; 9 Gao (B32) 2023; 8 Chen (B16) 2018; 9 Pajares (B86) 2020; 9 Deming (B22) 2018; 22 Yusuf (B125) 2023; 15 Griffioen (B40) 2018; 4 Cho (B19) 2020; 14 Sharma (B104) 2017 Dhaiban (B23) 2021; 3 Stefanis (B112) 2012; 2 Sever (B102) 2022; 23 Li (B68) 2020; 132 Mir Najib Ullah (B81) 2023; 11 Pasko (B90) 2022; 24 Radandish (B93) 2021; 12 Li (B67) 2003; 23 Konsman (B63) 2022; 15 Klann (B62) 2021; 13 Spiteri (B111) 2022; 143 Saleh (B98) 2022; 12 Zhang (B130) 2007; 45 Maghazachi (B73) 2013; 5 Burns (B10) 2023; 8 Mey (B80) 2023; 15 Cha (B13) 2023; 16 Turner (B116) 2016; 10 Holbrook (B48) 2021; 12 Papiri (B89) 2023; 45 Marogianni (B74) 2020; 21 Machado (B72) 2019; 71 Xu (B121) 2022; 17 Lamptey (B66) 2022; 23 Wilton (B119) 2020; 143 DiSabato (B26) 2016; 139 Mohandas (B82) 2009; 51 McQuade (B77) 2019; 431 Salehi (B99) 2018; 6 Kim (B61) 2021; 22 Gómez-Benito (B36) 2020; 11 Kanashiro (B54) 2020; 151 Ochocka (B84) 2021; 22 Kandpal (B55) 2022; 12 Zarrin (B128) 2021; 20 Harry (B45) 2008; 4 Fiebich (B31) 2018; 12 Gorecki (B37) 2021; 10 Palanisamy (B87) 2023; 13 Sharma (B105) 2023; 46 Ghasemi (B34) 2017; 19 Sharma (B106) 2021; 18 Sochocka (B110) 2017; 54 Hernández (B46) 2021; 2021 Mejzini (B78) 2019; 13 Rittiner (B95) 2020; 13 Ege (B29) 2021; 14 Shao (B103) 2022; 14 Sobue (B109) 2023; 43 Wang (B118) 2022; 11 Zahid (B126) 2019; 10 Gąssowska-Dobrowolska (B33) 2023; 24 Liu (B69) 2020; 21 Sivandzade (B108) 2021; 22 Turner (B115) 2014; 1843 Boros (B9) 2022; 19 Zhang (B132) 2023; 12 Paul (B91) 2021; 44 Blyufer (B8) 2021; 59 Mazzotta (B76) 2023; 12 Satarker (B100) 2022; 11 Aboudounya (B2) 2021; 2021 Guo (B42) 2021; 2021 Jung (B53) 2019; 7 Zang (B127) 2022; 14 Kennedy (B58) 2015 Diz-Chaves (B27) 2022; 23 Ansari (B4) 2023; 10 You (B124) 2023; 12 Han (B44) 2023; 39 Kwon (B65) 2020; 9 Abdelhamid (B1) 2022; 85 Qin (B92) 2023; 14 Zhang (B133) 2023; 51 Walton (B117) 2020; 26 Shen (B107) 2021; 13 Dilliott (B24) 2021; 6 Wu (B120) 2022; 2022 Kowalski (B64) 2019; 25 Gorji (B38) 2022; 23 Jia (B52) 2022; 13 Jain (B51) 2023; 15 Rivas-Fuentes (B96) 2021; 12 Cabeza-Cabrerizo (B11) 2021; 39 Hamilton (B43) 2020; 217 Chen (B17) 2023; 8 Tong (B114) 2016; 51 Sun (B113) 2023; 12 Hu (B49) 2023; 39 Lull (B71) 2010; 7 Kempuraj (B57) 2017; 11 Khan (B59) 2020; 1 Conte (B21) 2023; 12 Kanvinde (B56) 2022; 11 Yang (B122) 2020; 25 Yang (B123) 2020; 17 Masrori (B75) 2020; 27 Mortada (B83) 2021; 12 Giovannoni (B35) 2020; 41 Guo (B41) 2022; 14 Chen (B18) 2020; 10 Zhang (B129) 2021; 15 Clayton (B20) 2017; 11 Ronaldson (B97) 2020; 40 Chang (B14) 2017; 9 Fakhri (B30) 2022; 17 Bernardi (B6) 2012; 7 Ding (B25) 2021; 16 Reid (B94) 2021; 15 Biehl (B7) 2009; 24 Zhang (B131) 2023; 8 Ahmadi (B3) 2022; 13 Cenit (B12) 2017; 23 Meng (B79) 2023; 13 Palpagama (B88) 2019; 12 Seif (B101) 2017; 15 Duan (B28) 2022; 13 Zhou (B134) 2020; 14 Hung (B50) 2017; 24 Hol (B47) 2015; 32 Onyango (B85) 2021; 9 |
References_xml | – volume: 59 year: 2021 ident: B8 article-title: Riluzole: A neuroprotective drug with potential as a novel anti-cancer agent (Review). publication-title: Int. J. Oncol. doi: 10.3892/ijo.2021.5275 – volume: 4 start-page: 1265 year: 2008 ident: B45 article-title: Neuroinflammation and microglia: Considerations and approaches for neurotoxicity assessment. publication-title: Expert Opin. Drug Metab. Toxicol. doi: 10.1517/17425255.4.10.1265 – volume: 51 start-page: 55 year: 2009 ident: B82 article-title: Neurobiology of Alzheimer’s disease. publication-title: Indian J. Psychiatry doi: 10.4103/0019-5545.44908 – volume: 15 year: 2021 ident: B129 article-title: Microglia in Alzheimer’s disease: A target for therapeutic intervention. publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2021.749587 – volume: 19 start-page: 1145 year: 2022 ident: B9 article-title: Antisense oligonucleotides for the study and treatment of ALS. publication-title: Neurotherapeutics doi: 10.1007/s13311-022-01247-2 – volume: 12 year: 2023 ident: B21 article-title: Toll-like receptor 4 is upregulated in Parkinson’s Disease patients and co-localizes with pSer129αSyn: A possible link with the pathology. publication-title: Cells doi: 10.3390/cells12101368 – volume: 3 year: 2021 ident: B23 article-title: Role of peripheral immune cells in multiple sclerosis and experimental autoimmune encephalomyelitis. publication-title: Science doi: 10.3390/sci3010012 – volume: 9 year: 2020 ident: B65 article-title: Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes. publication-title: Transl. Neurodegen. doi: 10.1186/s40035-020-00221-2 – volume: 143 year: 2020 ident: B119 article-title: The contribution of glial cells to Huntington’s disease pathogenesis. publication-title: Neurobiol. Dis. doi: 10.1016/j.nbd.2020.104963 – volume: 14 year: 2022 ident: B127 article-title: The emerging role of central and peripheral immune systems in neurodegenerative diseases. publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2022.872134 – volume: 11 year: 2017 ident: B57 article-title: Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2017.00216 – volume: 23 start-page: 1605 year: 2003 ident: B67 article-title: Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.23-05-01605.2003 – volume: 26 start-page: 1816 year: 2020 ident: B117 article-title: Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. publication-title: Mult. Scler. doi: 10.1177/1352458520970841 – volume: 13 year: 2021 ident: B62 article-title: The gut-brain axis and its relation to Parkinson’s Disease: A review. publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2021.782082 – volume: 9 year: 2017 ident: B14 article-title: Tumor necrosis factor α Inhibition for Alzheimer’s Disease. publication-title: J. Cent. Nerv. Syst. Dis. doi: 10.1177/1179573517709278 – volume: 8 year: 2023 ident: B131 article-title: Role of neuroinflammation in neurodegeneration development. publication-title: Sig. Transduct. Target Ther. doi: 10.1038/s41392-023-01486-5 – volume: 2 year: 2012 ident: B112 article-title: α-Synuclein in Parkinson’s disease. publication-title: Cold Spring Harb. Perspect. Med. doi: 10.1101/cshperspect.a009399 – volume: 41 start-page: 805 year: 2020 ident: B35 article-title: The role of astrocytes in CNS inflammation. publication-title: Trends Immunol. doi: 10.1016/j.it.2020.07.007 – volume: 2021 year: 2021 ident: B2 article-title: COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. publication-title: Mediat. Inflamm. doi: 10.1155/2021/8874339 – volume: 7 start-page: 4927 year: 2012 ident: B6 article-title: Indomethacin-loaded lipid-core nanocapsules reduce the damage triggered by Aβ1-42 in Alzheimer’s disease models. publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S35333 – volume: 45 start-page: 27 year: 2007 ident: B130 article-title: Cytokines, inflammation, and pain. publication-title: Int. Anesthesiol. Clin. doi: 10.1097/AIA.0b013e318034194e – volume: 8 start-page: 42045 year: 2023 ident: B10 article-title: Nanophytomedicines as therapeutic agents for Parkinson’s Disease. publication-title: ACS Omega doi: 10.1021/acsomega.3c04862 – volume: 22 year: 2021 ident: B84 article-title: Microglia diversity in healthy and diseased brain: Insights from single-cell omics. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22063027 – volume: 51 year: 2023 ident: B133 article-title: PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis. publication-title: J. Int. Med. Res. doi: 10.1177/03000605231177191 – volume: 22 start-page: 587 year: 2018 ident: B22 article-title: Triggering receptor expressed on myeloid cells 2 (TREM2): A potential therapeutic target for Alzheimer disease? publication-title: Expert Opin. Ther. Targets doi: 10.1080/14728222.2018.1486823 – volume: 12 year: 2021 ident: B48 article-title: Neurodegenerative Disease and the NLRP3 Inflammasome. publication-title: Front. Pharmacol. doi: 10.3389/fphar.2021.643254 – volume: 1843 start-page: 2563 year: 2014 ident: B115 article-title: Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. publication-title: Biochim Biophys Acta Mol Cell Res. doi: 10.1016/j.bbamcr.2014.05.014 – volume: 44 start-page: 83 year: 2021 ident: B91 article-title: Signaling by cGAS–STING in neurodegeneration, neuroinflammation, and aging. publication-title: Trends Neurosci. doi: 10.1016/j.tins.2020.10.008 – volume: 24 year: 2017 ident: B50 article-title: Drug candidates in clinical trials for Alzheimer’s disease. publication-title: J. Biomed. Sci. doi: 10.1186/s12929-017-0355-7 – volume: 132 year: 2020 ident: B68 article-title: Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease. publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.110887 – volume: 45 start-page: 1443 year: 2023 ident: B89 article-title: Multiple sclerosis: Inflammatory and neuroglial aspects. publication-title: CIMB doi: 10.3390/cimb45020094 – volume: 10 start-page: 1347 year: 2020 ident: B18 article-title: Gene therapy for neurodegenerative disorders: Advances, insights and prospects. publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2020.01.015 – volume: 11 year: 2022 ident: B100 article-title: Astrocytic glutamatergic transmission and its implications in neurodegenerative disorders. publication-title: Cells doi: 10.3390/cells11071139 – volume: 23 year: 2022 ident: B102 article-title: Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23052400 – volume: 20 start-page: 39 year: 2021 ident: B128 article-title: Kinase inhibition in autoimmunity and inflammation. publication-title: Nat. Rev. Drug Discov. doi: 10.1038/s41573-020-0082-8 – volume: 7 year: 2019 ident: B53 article-title: Neuroinflammation as a factor of neurodegenerative disease: Thalidomide analogs as treatments. publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2019.00313 – volume: 4 year: 2018 ident: B40 article-title: Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington’s disease mice. publication-title: Heliyon doi: 10.1016/j.heliyon.2018.e00508 – volume: 9 year: 2020 ident: B86 article-title: Inflammation in Parkinson’s Disease: Mechanisms and therapeutic implications. publication-title: Cells doi: 10.3390/cells9071687 – volume: 39 start-page: 832 year: 2023 ident: B44 article-title: NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson’s Disease. publication-title: Neurosci. Bull. doi: 10.1007/s12264-023-01023-y – volume: 2022 year: 2022 ident: B120 article-title: Toll-like receptor 4: A promising therapeutic target for Alzheimer’s Disease. publication-title: Mediat. Inflamm. doi: 10.1155/2022/7924199 – volume: 32 start-page: 121 year: 2015 ident: B47 article-title: Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. publication-title: Curr. Opin. Cell Biol. doi: 10.1016/j.ceb.2015.02.004 – volume: 21 year: 2020 ident: B69 article-title: Stem cell-based therapies for Parkinson Disease. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21218060 – volume: 13 year: 2019 ident: B78 article-title: ALS genetics, mechanisms, and therapeutics: Where are we now? publication-title: Front. Neurosci. doi: 10.3389/fnins.2019.01310 – volume: 10 year: 2019 ident: B126 article-title: Pharmacological Inhibitors of the NLRP3 inflammasome. publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.02538 – volume: 24 start-page: 98 year: 2009 ident: B7 article-title: Introduction to Stem Cell Therapy. publication-title: J. Cardiovasc. Nurs. doi: 10.1097/JCN.0b013e318197a6a5 – volume: 17 start-page: 299 year: 2022 ident: B30 article-title: Nanoparticles in combating neuronal dysregulated signaling pathways: Recent approaches to the nanoformulations of phytochemicals and synthetic drugs against neurodegenerative diseases. publication-title: Int. J. Nanomed. doi: 10.2147/IJN.S347187 – volume: 39 start-page: 131 year: 2021 ident: B11 article-title: Dendritic cells revisited. publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-061020-053707 – volume: 13 start-page: 471 year: 2022 ident: B3 article-title: Non-steroidal anti-inflammatory drugs: Recent advances in the use of synthetic COX-2 inhibitors. publication-title: RSC Med. Chem. doi: 10.1039/d1md00280e – volume: 143 start-page: 179 year: 2022 ident: B111 article-title: Microglia and monocytes in inflammatory CNS disease: Integrating phenotype and function. publication-title: Acta Neuropathol. doi: 10.1007/s00401-021-02384-2 – volume: 12 year: 2023 ident: B132 article-title: Parkinson’s disease and gut microbiota: From clinical to mechanistic and therapeutic studies. publication-title: Transl. Neurodegen. doi: 10.1186/s40035-023-00392-8 – volume: 2021 year: 2021 ident: B46 article-title: Mesenchymal stem cell therapy for Alzheimer’s Disease. publication-title: Stem Cells Int. doi: 10.1155/2021/7834421 – volume: 14 year: 2022 ident: B41 article-title: Microglia polarization from M1 to M2 in neurodegenerative diseases. publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2022.815347 – volume: 11 year: 2022 ident: B56 article-title: Non-viral vectors for delivery of nucleic acid therapies for cancer. publication-title: BioTech doi: 10.3390/biotech11010006 – volume: 71 start-page: 556 year: 2019 ident: B72 article-title: PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease. publication-title: Pharmacol. Rep. doi: 10.1016/j.pharep.2018.11.005 – volume: 15 year: 2023 ident: B51 article-title: The role of gut microbiota in neurodegenerative diseases: Current insights and therapeutic implications. publication-title: Cureus doi: 10.7759/cureus.47861 – volume: 13 year: 2020 ident: B95 article-title: Gene-editing technologies paired with viral vectors for translational research into neurodegenerative diseases. publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2020.00148 – volume: 12 year: 2021 ident: B83 article-title: Immunotherapies for neurodegenerative diseases. publication-title: Front. Neurol. doi: 10.3389/fneur.2021.654739 – volume: 11 year: 2022 ident: B118 article-title: New insights into the gut microbiota in neurodegenerative diseases from the perspective of redox homeostasis. publication-title: Antioxidants doi: 10.3390/antiox11112287 – volume: 11 year: 2017 ident: B20 article-title: Alzheimer’s Disease: The role of microglia in brain homeostasis and proteopathy. publication-title: Front. Neurosci. doi: 10.3389/fnins.2017.00680 – volume: 12 year: 2023 ident: B124 article-title: Microglia and astrocytes in amyotrophic lateral sclerosis: Disease-associated states, pathological roles, and therapeutic potential. publication-title: Biology doi: 10.3390/biology12101307 – year: 2017 ident: B104 article-title: Stem cell therapy in pediatric neurological disabilities publication-title: Physical Disabilities - Therapeutic Implications doi: 10.5772/67656 – volume: 85 start-page: 1555 year: 2022 ident: B1 article-title: Probiotic Bifidobacterium breve prevents memory impairment through the reduction of both amyloid-β production and microglia activation in APP knock-in mouse. publication-title: J. Alzheimers Dis. doi: 10.3233/JAD-215025 – volume: 8 year: 2023 ident: B17 article-title: Macrophages in immunoregulation and therapeutics. publication-title: Sig. Transduct. Target Ther. doi: 10.1038/s41392-023-01452-1 – volume: 13 year: 2021 ident: B107 article-title: The association between the gut microbiota and parkinson’s disease, a meta-analysis. publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2021.636545 – volume: 18 year: 2021 ident: B106 article-title: A systemic immune challenge to model hospital-acquired infections independently regulates immune responses after pediatric traumatic brain injury. publication-title: J. Neuroinflamm. doi: 10.1186/s12974-021-02114-1 – volume: 24 year: 2023 ident: B33 article-title: Microglia and astroglia-the potential role in neuroinflammation induced by pre- and neonatal exposure to lead (Pb). publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms24129903 – volume: 19 start-page: 1 year: 2017 ident: B34 article-title: Multiple sclerosis: Pathogenesis. Symptoms, diagnoses and cell-based therapy publication-title: Cell J. – volume: 2021 year: 2021 ident: B42 article-title: The role of neutrophil extracellular traps in central nervous system diseases and prospects for clinical application. publication-title: Oxid. Med. Cell Longev. doi: 10.1155/2021/9931742 – volume: 14 year: 2022 ident: B103 article-title: Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration. publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2022.825086 – volume: 151 year: 2020 ident: B54 article-title: The role of neutrophils in neuro-immune modulation. publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2019.104580 – volume: 17 year: 2020 ident: B123 article-title: Anti-inflammatory protein TSG-6 secreted by bone marrow mesenchymal stem cells attenuates neuropathic pain by inhibiting the TLR2/MyD88/NF-κB signaling pathway in spinal microglia. publication-title: J. Neuroinflamm. doi: 10.1186/s12974-020-1731-x – volume: 1 start-page: 38 year: 2020 ident: B59 article-title: Dietary flavonoids in the management of Huntington’s Disease: Mechanism and clinical perspective. publication-title: eFood doi: 10.2991/efood.k.200203.001 – volume: 15 year: 2023 ident: B80 article-title: Neurodegeneration in multiple sclerosis. publication-title: WIREs Mech. Dis. doi: 10.1002/wsbm.1583 – volume: 14 year: 2020 ident: B134 article-title: TLR4 targeting as a promising therapeutic strategy for Alzheimer disease treatment. publication-title: Front. Neurosci. doi: 10.3389/fnins.2020.602508 – volume: 27 start-page: 1918 year: 2020 ident: B75 article-title: Amyotrophic lateral sclerosis: A clinical review. publication-title: Eur. J. Neurol. doi: 10.1111/ene.14393 – volume: 15 year: 2023 ident: B125 article-title: Nanoparticles as drug delivery systems: A review of the implication of nanoparticles’ physicochemical properties on responses in biological systems. publication-title: Polymers doi: 10.3390/polym15071596 – volume: 14 year: 2020 ident: B19 article-title: Role of edaravone as a treatment option for patients with amyotrophic lateral sclerosis. publication-title: Pharmaceuticals doi: 10.3390/ph14010029 – volume: 54 start-page: 8071 year: 2017 ident: B110 article-title: Inflammatory response in the CNS: Friend or Foe? publication-title: Mol. Neurobiol. doi: 10.1007/s12035-016-0297-1 – volume: 23 start-page: 5486 year: 2017 ident: B12 article-title: Influence of gut microbiota on neuropsychiatric disorders. publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v23.i30.5486 – volume: 14 year: 2021 ident: B29 article-title: Action mechanisms of curcumin in Alzheimer’s disease and its brain targeted delivery. publication-title: Materials doi: 10.3390/ma14123332 – volume: 8 year: 2023 ident: B32 article-title: Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets. publication-title: Sig. Transduct. Target Ther. doi: 10.1038/s41392-023-01588-0 – volume: 21 year: 2020 ident: B74 article-title: Neurodegeneration and inflammation-an interesting interplay in Parkinson’s Disease. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21228421 – volume: 6 year: 2021 ident: B24 article-title: Contribution of rare variant associations to neurodegenerative disease presentation. publication-title: npj Genom. Med. doi: 10.1038/s41525-021-00243-3 – volume: 23 year: 2022 ident: B38 article-title: Neuroinflammation: The pathogenic mechanism of neurological disorders. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23105744 – volume: 13 year: 2022 ident: B28 article-title: Toll-like receptor signaling and its role in cell-mediated immunity. publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.812774 – volume: 15 year: 2022 ident: B63 article-title: Cytokines in the brain and neuroinflammation: We didn’t starve the fire! publication-title: Pharmaceuticals doi: 10.3390/ph15020140 – start-page: 1 year: 2015 ident: B58 article-title: Neuroimmune signaling: Cytokines and the CNS publication-title: Neuroscience in the 21st Century doi: 10.1007/978-1-4614-6434-1_174-1 – volume: 11 year: 2023 ident: B81 article-title: Nanomedicine in the management of Alzheimer’s Disease: State-of-the-art. publication-title: Biomedicines doi: 10.3390/biomedicines11061752 – volume: 5 start-page: 363 year: 2013 ident: B73 article-title: On the role of natural killer cells in neurodegenerative diseases. publication-title: Toxins doi: 10.3390/toxins5020363 – volume: 10 year: 2023 ident: B4 article-title: The role of probiotics and prebiotics in modulating of the gut-brain axis. publication-title: Front. Nutr. doi: 10.3389/fnut.2023.1173660 – volume: 12 year: 2023 ident: B113 article-title: Microglia-astrocyte interaction in neural development and neural pathogenesis. publication-title: Cells doi: 10.3390/cells12151942 – volume: 9 year: 2015 ident: B5 article-title: Elusive roles for reactive astrocytes in neurodegenerative diseases. publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2015.00278 – volume: 13 start-page: 4138 year: 2023 ident: B87 article-title: New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs). publication-title: Theranostics doi: 10.7150/thno.83066 – volume: 12 year: 2018 ident: B31 article-title: Role of microglia TLRs in neurodegeneration. publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2018.00329 – volume: 217 year: 2020 ident: B43 article-title: GM-CSF in inflammation. publication-title: J. Exp. Med. doi: 10.1084/jem.20190945 – volume: 43 year: 2023 ident: B109 article-title: Neuroinflammation in Alzheimer’s disease: Microglial signature and their relevance to disease. publication-title: Inflamm. Regen. doi: 10.1186/s41232-023-00277-3 – volume: 431 start-page: 1805 year: 2019 ident: B77 article-title: Microglia in Alzheimer’s Disease: Exploring how genetics and phenotype influence risk. publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2019.01.045 – volume: 40 start-page: S6 year: 2020 ident: B97 article-title: Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity. publication-title: J. Cereb. Blood Flow Metab. doi: 10.1177/0271678X20951995 – volume: 13 start-page: 20476 year: 2023 ident: B79 article-title: Recent advances in small molecules for improving mitochondrial disorders. publication-title: RSC Adv. doi: 10.1039/D3RA03313A – volume: 46 start-page: 56 year: 2023 ident: B105 article-title: Role of NLRP3 inflammasome and its inhibitors as emerging therapeutic drug candidate for Alzheimer’s disease: A review of mechanism of activation. publication-title: Regul. Inhibit. Inflamm. doi: 10.1007/s10753-022-01730-0 – volume: 10 year: 2016 ident: B116 article-title: Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2016.00056 – volume: 25 year: 2020 ident: B122 article-title: Nanoformulations to enhance the bioavailability and physiological functions of polyphenols. publication-title: Molecules doi: 10.3390/molecules25204613 – volume: 12 year: 2023 ident: B76 article-title: Synucleinopathies take their toll: Are TLRs a way to go? publication-title: Cells doi: 10.3390/cells12091231 – volume: 13 year: 2022 ident: B52 article-title: Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics. publication-title: Front. Immunol. doi: 10.3389/fimmu.2022.1088124 – volume: 10 year: 2019 ident: B70 article-title: Roles of GM-CSF in the pathogenesis of autoimmune diseases: An update. publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01265 – volume: 7 start-page: 354 year: 2010 ident: B71 article-title: Microglial activation and chronic neurodegeneration. publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2010.05.014 – volume: 15 year: 2021 ident: B94 article-title: She doesn’t even go here: The role of inflammatory astrocytes in CNS disorders. publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2021.704884 – volume: 9 year: 2021 ident: B15 article-title: Exosomes, a New star for targeted delivery. publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2021.751079 – volume: 103 start-page: 820 year: 2019 ident: B39 article-title: TREM2 Acts downstream of CD33 in modulating microglial pathology in Alzheimer’s Disease. publication-title: Neuron doi: 10.1016/j.neuron.2019.06.010 – volume: 22 year: 2021 ident: B61 article-title: New avenues for the treatment of Huntington’s Disease. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22168363 – volume: 6 year: 2018 ident: B99 article-title: Resveratrol: A double-edged sword in health benefits. publication-title: Biomedicines doi: 10.3390/biomedicines6030091 – volume: 16 start-page: 1702 year: 2021 ident: B25 article-title: Astrocytes: A double-edged sword in neurodegenerative diseases. publication-title: Neural Regen. Res. doi: 10.4103/1673-5374.306064 – volume: 17 start-page: 1927 year: 2022 ident: B121 article-title: Nanomedicine: An emerging novel therapeutic strategy for hemorrhagic stroke. publication-title: IJN doi: 10.2147/IJN.S357598 – volume: 23 year: 2022 ident: B27 article-title: Anti-Inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23179583 – volume: 9 start-page: 7204 year: 2018 ident: B16 article-title: Inflammatory responses and inflammation-associated diseases in organs. publication-title: Oncotarget doi: 10.18632/oncotarget.23208 – volume: 12 start-page: 571 year: 2021 ident: B96 article-title: Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review. publication-title: J. Cancer doi: 10.7150/jca.47022 – volume: 12 start-page: S201 year: 2022 ident: B98 article-title: Therapeutic strategies for immune transformation in Parkinson’s Disease. publication-title: J. Parkinsons Dis. doi: 10.3233/JPD-223278 – volume: 22 year: 2021 ident: B108 article-title: Regenerative stem cell therapy for neurodegenerative diseases: An overview. publication-title: IJMS doi: 10.3390/ijms22042153 – volume: 24 year: 2022 ident: B90 article-title: Modeling of neurodegenerative diseases: “Step by Step” and “Network” organization of the complexes of model systems. publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms24010604 – volume: 16 start-page: 22 year: 2023 ident: B13 article-title: Current status and future perspectives on stem cell-based therapies for Parkinson’s Disease. publication-title: J. Mov. Disord. doi: 10.14802/jmd.22141 – volume: 12 year: 2019 ident: B88 article-title: The role of microglia and astrocytes in Huntington’s disease. publication-title: Front. Mol. Neurosci. doi: 10.3389/fnmol.2019.00258 – volume: 11 year: 2020 ident: B36 article-title: Modeling Parkinson’s disease with the alpha-synuclein protein. publication-title: Front. Pharmacol. doi: 10.3389/fphar.2020.00356 – volume: 139 start-page: 136 year: 2016 ident: B26 article-title: Neuroinflammation: The devil is in the details. publication-title: J. Neurochem. doi: 10.1111/jnc.13607 – volume: 12 year: 2022 ident: B55 article-title: Dysbiosis of gut microbiota from the perspective of the gut-brain axis: Role in the provocation of neurological disorders. publication-title: Metabolites doi: 10.3390/metabo12111064 – volume: 15 year: 2023 ident: B60 article-title: Effects of gut microbiota on neurodegenerative diseases. publication-title: Front. Aging Neurosci. doi: 10.3389/fnagi.2023.1145241 – volume: 51 start-page: 123 year: 2016 ident: B114 article-title: T3D-959: A multi-faceted disease remedial drug candidate for the treatment of Alzheimer’s Disease. publication-title: JAD doi: 10.3233/JAD-151013 – volume: 14 year: 2023 ident: B92 article-title: Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and development efforts. publication-title: Front. Neurol. doi: 10.3389/fneur.2023.1103416 – volume: 15 year: 2017 ident: B101 article-title: The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. publication-title: Cell Commun. Signal. doi: 10.1186/s12964-017-0177-y – volume: 25 start-page: 48 year: 2019 ident: B64 article-title: Brain-gut-microbiota axis in Alzheimer’s Disease. publication-title: J. Neurogastroenterol. Motil. doi: 10.5056/jnm18087 – volume: 12 year: 2021 ident: B93 article-title: The role of distinct subsets of macrophages in the pathogenesis of MS and the impact of different therapeutic agents on these populations. publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.667705 – volume: 9 year: 2021 ident: B85 article-title: Neuroinflammation in Alzheimer’s Disease. publication-title: Biomedicines doi: 10.3390/biomedicines9050524 – volume: 10 year: 2021 ident: B37 article-title: TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut. publication-title: Transl. Neurodegener. doi: 10.1186/s40035-021-00271-0 – volume: 39 start-page: 541 year: 2023 ident: B49 article-title: Interactions between astrocytes and oligodendroglia in myelin development and related brain diseases. publication-title: Neurosci. Bull. doi: 10.1007/s12264-022-00981-z – volume: 23 year: 2022 ident: B66 article-title: Review of the common neurodegenerative disorders: Current therapeutic approaches and the potential role of nanotherapeutics. publication-title: IJMS doi: 10.3390/ijms23031851 |
SSID | ssj0000330058 |
Score | 2.6216905 |
SecondaryResourceType | review_article |
Snippet | Neuroinflammation refers to a highly complicated reaction of the central nervous system (CNS) to certain stimuli such as trauma, infection, and... |
SourceID | doaj proquest pubmed crossref |
SourceType | Open Website Aggregation Database Index Database Enrichment Source |
StartPage | 1347987 |
SubjectTerms | Alzheimer's disease Amyotrophic lateral sclerosis Brain research Cell therapy Central nervous system Chemokines Chronic illnesses Cytokines Disease Glial cells Immune response Immune response (cell-mediated) Immune system Infections Inflammation Injuries Movement disorders Multiple sclerosis Nanoparticles Neurodegeneration neurodegenerative disease Neurodegenerative diseases neuroinflammation Neurological disorders Neuronal-glial interactions Parkinson's disease Reactive nitrogen species Reactive oxygen species Therapeutic targets Trauma Viral infections |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dS8MwEA_ig_gifludEsE3qWubNEl9U3EMYT452FtoskQE6dRt_793STf6or74VEivkN5d7nLc3e8IuSqlYbxkJuVKsBQBydOqKstUGVAWZcBoSmxwHj2L4Zg_TcpJZ9QX1oRFeODIuH5hGWdOePAtlhsjTO29qqwVuRW1UBatL_i8TjAVbDBDGHYVu2QgCqv6Hqf-QDxY8JvQPYk1dB1PFAD7f75lBm8z2CU77TWR3sXt7ZEN1-yTrVGbCD8gnyBeipWBdOZpwKQETQHhxkZE-tbExal7DbDSaNNom4uZ31IbQZnostvZQuFBI8QI7XRl0VgrPj8k48Hjy8MwbacnpBauOItU5r6oCiEdU1M3zVUG7KvrUlgceV5m3MppwRVTpYdTLatM1BDscQi0a-WcVI4dkc1m1rgTQr3JfM48JhErROxT3knPPLOOA2EhE5KvOKltCy2OEy7eNYQYyH0duK-R-7rlfkKu1998RGCNX6nvUUBrSgTFDgugKrpVFf2XqiSktxKvbk_qXKM2YrFNxhJyuX4NZwwTJ3XjZkuk4YpXiD2fkOOoFuudMCVC6vX0P3Z4Rrbxr9OAJdkjm4uvpTuHS8_CXAT9_gaKnP-r priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Na90wDDdbB2OX0q5bm7UdHuxWvCbxZ3YZa1kpg-60wruZ2LHLoCRt33v__yTbL3uX9RRw7BBLsi1Z0k-EfJbacSG5Y8IozhCQnHWdlMw4EBbjYNPUmOB880td34qfC7koF27LEla52RPTRj1MHu_Iz3EUBkXU_NvDI8OqUehdLSU0XpJXCF2GUq0Xer5jqTmCsadsOIV_wpXMeTNgl3XnEesAgYXYii8pnxKj6rbOpgTh_3-9M50_V3tktyiO9Hvm9D55Eca35PVNcY0fkEdgOMVYQTpFmlAqQXaA3Tk1kf4Zc-MQ7hLQNO5ytHhnll-pzzBNdL2d60LhQTPoCN3K06I5enz5jtxe_fh9ec1KPQXmQelZMd3EtmuVDtwMYWhM7YXre6k8FkGXtfB6aIXhRkZY57qrVQ_mnwDTuzchaBP4e7IzTmM4IjS6OjY8oluxQww_E4OOPHIfBHRsdUWaDSWtL2DjWPPi3oLRgdS3ifoWqW8L9StyNo95yFAbz_a-QAbNPREmOzVMT3e2rDrbei54UBEUE5irU66P0XTeq8arXhlfkZMNe21Zu0v7T9Iq8ml-DasOXSn9GKY19hFGdIhGX5HDLBbzn3CjkjP2w_MfPyZvcD4s4UaekJ3V0zqcgoKzch-TFP8Fbez33Q priority: 102 providerName: ProQuest |
Title | The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38681666 https://www.proquest.com/docview/3037199703 https://www.proquest.com/docview/3048494522 https://doaj.org/article/2c343e6f023c4bb6baff89cc61c6a68c |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3raxQxEB_6APGL-Ha1HhH8Jlt3N88VRKy0FuGKiAf3LWxySSmUPXsPaP97Z5K9o4IVv-zC7mRJZibJzE7mNwBvpXZcSO5KYRQvCZC8bFspS-NQWYzDRVNTgvP4TJ1OxLepnO7AptzRwMDlX107qic1WVweXl_dfMIJ_5E8Ttxv30cq6IOuXiMOU2Kk0buwjzuTpooG48HcTyszJ3D2lB2nqGdcyZxHc8dn_tirEqT_3XZo2o9OHsKDwZBkn7PkH8FO6B_DvfEQKn8CV6gAjM4OsnlkCbUSR4fiz6mK7KLPD2fhPAFP06rHhmjN8gPzGbaJrW_nvjC8sQxCwm7lbbF8mnz5FCYnxz-_nJZDfYXSoxG0KnUdm7ZROnAzC7PaVF64rpPKU1F0WQmvZ40w3MiI8163lerQHRToincmBG0CfwZ7_bwPL4BFV8WaRwoztoTpZ2LQkUfug0DCRhdQbzhp_QA-TjUwLi06IcR9m7hvift24H4B77ZtfmXojX9SH5GAtpQEm50ezBfndpiFtvFc8KAiGio4VqdcF6NpvVe1V50yvoCDjXjtRhUt6Ssdx6l4AW-2r3EWUmil68N8TTTCiJbQ6Qt4ntVi2xNuVArOvvyP1q_gPg2qTGCSB7C3WqzDa7R6Vm4Eu3qqR7B_dHz2_cco_TvA69dpPUpK_huRVAJk |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxJtAASPBCYUmsWM7SAjxqra021Mr7c0kjl0hoaTt7grxp_iNzNhJ2Au99RQpcaJ4_Hns8cx8A_CqVA0XJW9SoSVPiZA8raqyTHWDYNENKk1FCc7zIzk7Ed8W5WIL_oy5MBRWOerEoKjb3tIZ-S69RUERGf9wdp5S1Sjyro4lNCIsDtzvX2iyLd_vf8HxfV0Ue1-PP8_SoapAanHpX6Uq90VVSOW4bl2b68yKpq5LaakUeJkJq9pCaK5Lj2hXVSZrNIIEGqC1dk5px_G71-A6LrwZGXtqoaYznYwT-XvIvpPUcy7LmKeDdmC166nuEFqkhXgb8jcpim9jLQwlA_6_zw3r3d4duD1sVNnHiKy7sOW6e3BjPrji78M5AoxRbCLrPQusmIhVhFdMhWQ_unizdaeB2Jq0Khu8Qct3zEZaKLbezK1heGGR5IRt5IWxGK2-fAAnVyLph7Dd9Z17DMw3mc-5JzdmRZyB2jvluefWCWxYqATyUZLGDuTmVGPjp0Ejh6RvgvQNSd8M0k_gzfTOWaT2uLT1JxqgqSXRcocb_cWpGWa5KSwX3EmPGyHsayOb2ntdWStzK2upbQI74_CaQVcszT9kJ_ByeoyznFw3def6NbURWlTEfp_AowiL6U-4lsH5--Tyj7-Am7Pj-aE53D86eAq3qG9p4Kzcge3Vxdo9w83VqnkeEM3g-1VPob8CLDMh |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrVRxQbwJFDASnFDYJHZsBwkhSrtqKV1ViEq9uYljV0goabu7Qvw1fh0zzoO90FtPkRInSsafJzOemW8AXueq4iLnVSy05DERksdFkeexrhAsukKlqajA-Wgu90_El9P8dAP-DLUwlFY56MSgqOvW0h75lO6ipIiET32fFnG8O_t4cRlTBymKtA7tNDqIHLrfv9B9W3w42MW5fpNls73vn_fjvsNAbNEMWMYq9VmRSeW4rl2d6sSKqixzaakteJ4Iq-pMaK5zj8hXRSJLdIgEOqOldk5px_G5t2BTkVc0gc2dvfnxt3GHJ-FEBR9q8STJgcu8q9pBr7CYeupChP5pJt6Fak7K6Vv7M4YGAv-3esPfb3YX7vRmK_vU4ewebLjmPmwd9YH5B3CJcGOUqchazwJHJiIXwdYVRrIfTXeydueB5pp0LOtjQ4v3zHYkUWy1XmnD8MA6yhO2ViXGutz1xUM4uRFZP4JJ0zbuCTBfJT7lnoKaBTEIau-U555bJ3BgpiJIB0ka21OdU8eNnwZdHpK-CdI3JH3TSz-Ct-M9Fx3Rx7Wjd2iCxpFE0h1OtFfnpl_zJrNccCc9mkX4rZWsSu91Ya1MrSylthFsD9Nres2xMP9wHsGr8TKueQrklI1rVzRGaFEQF34EjztYjG_CtQyh4KfXP_wlbOHyMV8P5ofP4DZ9WhwILLdhsrxauedoaS2rFz2kGZzd9Cr6C6XmOLw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+neuroinflammation+in+neurodegenerative+diseases%3A+current+understanding+and+future+therapeutic+targets&rft.jtitle=Frontiers+in+aging+neuroscience&rft.au=Adamu%2C+Alhamdu&rft.au=Li%2C+Shuo&rft.au=Gao%2C+Fankai&rft.au=Xue%2C+Guofang&rft.date=2024-04-12&rft.issn=1663-4365&rft.eissn=1663-4365&rft.volume=16&rft.spage=1347987&rft_id=info:doi/10.3389%2Ffnagi.2024.1347987&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-4365&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-4365&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-4365&client=summon |